Your fact-checks will appear here
The potential cognitive benefits of Bacopa monnieri, including improvements in memory and learning.
High-quality, long-duration randomized controlled trials (RCTs proving durable cognitive benefits or long‑term safety for popular nootropic supplements are scarce: most human trials are small, short (...
Bacopa monnieri shows modest, reproducible benefits for certain types of memory and some anxiety measures in randomized trials, typically at 300–600 mg/day over ~12 weeks, but evidence is limited by s...
Independent clinical evidence for Neurocept’s key ingredients is uneven: Bacopa monnieri has the largest body of randomized trials and systematic reviews suggesting modest cognitive benefits—particula...
Neurocept’s public materials highlight several ingredients with independent scientific literature suggesting potential cognitive benefits—most notably Bacopa monnieri, phosphatidylserine, Ginkgo bilob...
Clinical trial evidence supports modest cognitive effects for — particularly improvements in memory recall and speed/attention — based on multiple randomized trials and systematic reviews, but benefit...
Randomized controlled trials and systematic reviews indicate that Bacopa monnieri produces modest, domain‑specific cognitive benefits—particularly in attention, processing speed, and some memory tests...
Randomized, double-blind, placebo-controlled trials have reported improvements in working memory or attention for several nutraceuticals—most consistently for Bacopa monnieri, some Ginkgo biloba trial...
A handful of Brain Defender’s ingredients—Bacopa monnieri, citicoline/alpha‑GPC (choline donors), and phosphatidylserine—have the clearest clinical signal for modest memory benefits in older adults, w...